Ben A Calvert
Overview
Explore the profile of Ben A Calvert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roth D, Sahin A, Ling F, Tepho N, Senger C, Quiroz E, et al.
Nat Commun
. 2025 Mar;
16(1):2446.
PMID: 40069153
Mucociliary clearance is a vital defense mechanism of the human airways, protecting against harmful particles and infections. When this process fails, it contributes to respiratory diseases like chronic obstructive pulmonary...
2.
Murthy S, Seabold D, Gautam L, Caceres A, Sease R, Calvert B, et al.
Am J Physiol Lung Cell Mol Physiol
. 2025 Feb;
PMID: 39982813
Bronchial epithelial cells derived from the tracheo-bronchial regions of human airways (HBECs) provide a valuable model for studying pathological mechanisms and evaluating therapeutics. This cell population comprises a mixed population...
3.
Koc-Gunel S, Liu E, Gautam L, Calvert B, Murthy S, Harriott N, et al.
JCI Insight
. 2025 Feb;
PMID: 39903528
Lymphangioleiomyomatosis (LAM) is a progressive lung disease with limited treatments, largely due to an incomplete understanding of its pathogenesis. Lymphatic endothelial cells (LECs) invade LAM cell clusters, which include HMB-45-positive...
4.
St Pierre L, Berhan A, Sung E, Alvarez J, Wang H, Ji Y, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Nov;
1871(3):167572.
PMID: 39547519
Idiopathic pulmonary fibrosis (IPF) is a lethal progressive lung disease urgently needing new therapies. Current treatments only delay disease progression, leaving lung transplant as the sole remaining option. Recent studies...
5.
Murthy S, Seabold D, Gautam L, Caceres A, Sease R, Calvert B, et al.
bioRxiv
. 2024 Sep;
PMID: 39282256
Human bronchial epithelial cells (HBECs) derived from the tracheo-bronchial regions of human airways provide an excellent model for studying pathological mechanisms and evaluating therapeutics in human airway cells. This cell...
6.
Roth D, Sahin A, Ling F, Senger C, Quiroz E, Calvert B, et al.
Res Sq
. 2024 May;
PMID: 38746209
Our study focuses on the intricate connection between tissue-level organization and ciliated organ function in humans, particularly in understanding the morphological organization of airways and their role in mucociliary clearance....
7.
Roth D, Sahin A, Ling F, Tepho N, Senger C, Quiroz E, et al.
bioRxiv
. 2024 Jan;
PMID: 38187619
Mucociliary clearance is a vital defense mechanism of the human airways, protecting against harmful particles and infections. When this process fails, it contributes to respiratory diseases like chronic obstructive pulmonary...
8.
Koc-Gunel S, Liu E, Gautam L, Calvert B, Murthy S, Harriott N, et al.
bioRxiv
. 2023 Jul;
PMID: 37398026
Lymphangioleiomyomatosis (LAM) is a progressive lung disease with limited treatments, largely due to an incomplete understanding of its pathogenesis. Lymphatic endothelial cells (LECs) invade LAM cell clusters, which include HMB-45-positive...
9.
Calvert B, Quiroz E, Lorenzana Z, Doan N, Kim S, Senger C, et al.
Front Immunol
. 2023 Apr;
14:1112870.
PMID: 37006263
Introduction: In response to viral infection, neutrophils release inflammatory mediators as part of the innate immune response, contributing to pathogen clearance through virus internalization and killing. Pre- existing co-morbidities correlating...
10.